CUSIP 16385C104SPONSORED ADSCMMBQ2 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ2 2025
14 funds hold this security · Q2 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 1.61M | $1.87M | +1.50M | Added |
| 2 | Orbimed Advisors LLC | 941.0K | $1.09M | −800.3K | Reduced |
| 3 | Sphera Funds Management Ltd. | 738.0K | $856.1K | −162.4K | Reduced |
| 4 | Yelin Lapidot Holdings Management Ltd. | 578.3K | $670.8K |
| 0 |
| Held |
| 5 | Ikarian Capital, LLC | 213.1K | $247.1K | 0 | Held |
| 6 | Rhumbline Advisers | 39.9K | $46.2K | +16.0K | Added |
| 7 | Kestra Private Wealth Services, LLC | 31.2K | $36.2K | 0 | Held |
| 8 | Boothbay Fund Management, LLC | 26.2K | $30.4K | 0 | Held |
| 9 | Jane Street Group, LLC | 20.6K | $23.9K | +20.6K | New |
| 10 | Bnp Paribas Financial Markets | 13.9K | $16.1K | +3.4K | Added |
See every fund holding Chemomab Therapeutics Ltd, with full quarter-over-quarter share changes.
Unlock all holders